Comparator Drug Supplier

Biosimilars in clinical trials & key regulatory considerations

The growth in the biosimilar market since 2006 has been significant. Biosimilars have no meaningful clinical differences between the...

Mission Impossible Case Study

Mission impossible: case study Here is a success story that shows just how CSI can support your clinical trial supplies. CSI managed to...

Innovation delivered: oncology drug development

Innovation in oncology drug development is granting cancer patients access to life-changing therapies. The industry continues to conduct...

Saving hundreds of thousands of euros to a biotech company

The client was running clinical trials with its investigational product in many different countries. The product is administered in...

12 Case Studies of Christmas

Take a look at CSI's 12 case studies of christmas 2020 has been a challenging year, with product shortages, borders closing, and more...

Blockbuster oncology products in clinical trials supplies

This is relevant for clinical trials as more regulators require evidence of efficacy in comparison to the standard of care, which is...

Identifying risks in clinical trial supplies & comparator sourcing

Webinar: how to identify and manage risks in clinical trial supplies and comparator sourcing CSI hosted a webinar with Xtalks on Monday,...

News and Insights